CX 2024 Programme
Day 2: Venous & Lymphatic Controversies - Wednesday, 24th April
Venue: Theatre 2
Time: 08:00 - 18:00
Appropriate Care Controversies
Time: 08:00 - 09:40
| Anchor: | Erin Murphy, Charlotte, United States |
| Moderators: | Manj Gohel, Cambridge, United Kingdom |
| Stephen Black, London, United Kingdom |
08:00 - 08:05
Anatomical disease classification to optimise decision making and outcomes for deep venous recanalisation procedures
| Speaker: | Houman Jalaie, Aachen, Germany |
08:05 - 08:10
Audience participation & discussion
08:10 - 08:15
Summary of latest guidelines regarding optimal use of IVC filters
| Speaker: | Tze Chan, Liverpool, United Kingdom |
08:15 - 08:20
Audience participation & discussion
08:20 - 08:25
Optimum outcomes and duration of follow-up in acute and chronic deep venous trials
| Speaker: | Steven Abramowitz, Washington D.C., United States |
08:25 - 08:30
Audience participation & discussion
08:30 - 08:35
Venous outcomes that should be measured in routine clinical practice
| Speaker: | Daniel Carradice, Kingston upon Hull, United Kingdom |
08:35 - 08:40
Audience participation & discussion
08:40 - 08:45
Current status of DOACs in the prevention and treatment of venous thromboembolic disease
| Speaker: | Armando Mansilha, Porto, Portugal |
08:45 - 08:50
Audience participation & discussion
08:50 - 08:55
Optimal management strategy for incompetent perforators: Indications and techniques
| Speaker: | Steve Elias, Englewood, United States |
08:55 - 09:00
Audience participation & discussion
09:00 - 09:05
Potential interventions for chronic femoropopliteal deep venous obstruction
| Speaker: | David Dexter, Virginia Beach, United States |
09:05 - 09:10
Audience participation & discussion
09:10 - 09:15
Underutilisation of thrombus removal intervention for pulmonary emboli
| Speaker: | Patrick Muck, Cincinnati, United States |
09:15 - 09:20
Audience participation & discussion
09:20 - 09:25
Lytic-free options for early thrombus removal in acute pulmonary embolus
| Speaker: | Mahmood Razavi, Stockton, United States |
09:25 - 09:30
Audience participation & discussion
09:30 - 09:35
Update on STRIKE PE study using computer-aided thrombectomy for pulmonary embolism
| Speaker: | Andrew Sharp, Cardiff, United Kingdom |
09:35 - 09:40
Audience participation & discussion
Sponsored Education
Time: 09:40 - 10:10
Coffee break
Time: 10:10 - 10:30
Deep Venous Controversies
Time: 10:30 - 12:30
| Anchor: | Armando Mansilha, Porto, Portugal |
| Moderators: | Kathleen Gibson, Bellevue, United States |
| Manj Gohel, Cambridge, United Kingdom |
10:30 - 10:40
Debate: Treatment of non-thrombotic iliac vein lesions in C3-C6 disease is supported by the clinical evidence
For the motion
10:30 - 10:35
| Steve Elias, Englewood, United States |
Against the motion
10:35 - 10:40
| Gerard O’Sullivan, Galway, Ireland |
10:40 - 10:50
Audience participation & discussion
10:50 - 10:55
Podium First: Defining the need for a dedicated IVC stent
| Speaker: | Stephen Black, London, United Kingdom |
10:55 - 11:00
Audience participation & discussion
11:00 - 11:05
Optimal algorithm for managing combined iliac outflow obstruction and pelvic venous disease
| Speaker: | Gloria Salazar, Chapel Hill, United States |
11:05 - 11:10
Audience participation & discussion
11:10 - 11:15
Mechanical thrombectomy for early thrombus removal in DVT: Current landscape
| Speaker: | Kush Desai, Chicago, United States |
11:15 - 11:20
Audience participation & discussion
11:20 - 11:25
When and how to manage patients presenting with acute DVT and underlying culprit lesion
| Speaker: | Efthymios Avgerinos, Athens, Greece |
11:25 - 11:30
Audience participation & discussion
11:30 - 11:35
Technical approach to venous stenting in NIVL patient: From patient selection to post-procedure care
| Speaker: | Gerard O’Sullivan, Galway, Ireland |
11:35 - 11:40
Audience participation & discussion
11:40 - 11:45
Podium First: Efficacy results of the SAVVE trial: Long-term results use of a bioprosthetic valve, for patients with chronic deep venous reflux
| Speaker: | David Dexter, Virginia Beach, United States |
11:45 - 11:50
Audience participation & discussion
11:50 - 11:55
Summary of currently available venous stent trial data
| Speaker: | Erin Murphy, Charlotte, United States |
11:55 - 12:00
Audience participation & discussion
12:00 - 12:05
Edited Case: Complex deep venous recanalisation with inflow disease
| Speaker: | Marie Josee Van Rijn, Nijmegen, Netherlands |
12:05 - 12:10
Audience participation & discussion
12:10 - 12:15
Ideal strategy for maintaining venous stent patency: Role of surveillance, thresholds for re-intervention and anticoagulation tactics
| Speaker: | Houman Jalaie, Aachen, Germany |
12:15 - 12:20
Audience participation & discussion
12:20 - 12:25
VIVID study: 12-month outcomes
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
12:25 - 12:30
Audience participation & discussion
Sponsored Education
Time: 12:30 - 13:00
Lunch break
Time: 13:00 - 13:30
Superficial Venous Controversies
Time: 13:30 - 15:20
| Anchor: | Armando Mansilha, Porto, Portugal |
| Moderators: | Erin Murphy, Charlotte, United States |
| Stephen Black, London, United Kingdom |
13:30 - 13:40
Debate: Compression should be routine after endovenous interventions
For the motion
13:30 - 13:35
| Alun Davies, London, United Kingdom |
Against the motion
13:35 - 13:40
| Nicolas Neaume, Toulouse, France |
13:40 - 13:50
Audience participation & discussion
13:50 - 13:55
The role of phlebectomy alone without saphenous ablation for varicose veins: Insights from the SAPTAP trial
| Speaker: | Eveline Scheerders, Rotterdam, Netherlands |
13:55 - 14:00
Audience participation & discussion
14:00 - 14:05
Edited Case: Foam sclerotherapy augmented phlebotomies for optimal varicosity management
| Speaker: | Raghu Kolluri, Columbus, United States |
14:05 - 14:10
Audience participation & discussion
14:10 - 14:15
Podium First: Results of the SYNCHRONOUS trial to evaluate the role of prophylactic AASV ablation
| Speaker: | Tobias Hirsch, Halle, Germany |
14:15 - 14:20
Audience participation & discussion
14:20 - 14:25
Management algorithm for the use of compression after superficial and deep venous intervention
| Speaker: | Tristan Lane, Cambridge, United Kingdom |
14:25 - 14:30
Audience participation & discussion
14:30 - 14:35
Endovenous thermal ablation modalities should not be considered the same
| Speaker: | Isaac Nyamekye, Worcester, United Kingdom |
14:35 - 14:40
Audience participation & discussion
14:40 - 14:45
The justification for, and success of, treatments for prominent hand and face veins
| Speaker: | Aleksandra Jaworucka-Kaczorowska, Gorzow Wielkopolski, Poland |
14:45 - 14:50
Audience participation & discussion
14:50 - 14:55
Safety considerations after endovenous interventions
| Speaker: | Stephen Black, London, United Kingdom |
14:55 - 15:00
Audience participation & discussion
15:00 - 15:05
Podium First: Randomised clinical trials comparing cyanoacrylate glue closure with thermal ablation and surgical stripping: Study design and methodology
| Speaker: | Manj Gohel, Cambridge, United Kingdom |
15:05 - 15:10
Podium First: Randomised clinical trials comparing cyanoacrylate glue closure with thermal ablation and surgical stripping: Data outcomes and results
| Speaker: | Kathleen Gibson, Bellevue, United States |
15:10 - 15:20
Audience participation & discussion
Sponsored Education
Time: 15:20 - 15:50
Tea break
Time: 15:50 - 16:10
Venous Ulcer and Lymphatic Controversies
Time: 16:10 - 17:10
| Anchor: | Stephen Black, London, United Kingdom |
| Moderators: | Erin Murphy, Charlotte, United States |
| Alun Davies, London, United Kingdom |
16:10 - 16:15
Edited Case: Venous ulcer management in a patient with extensive venous outflow obstruction
| Speaker: | Andrew Wigham, Oxford, United Kingdom |
16:15 - 16:20
Audience participation & discussion
16:20 - 16:25
Algorithm for management of no-hope leg ulcers
| Speaker: | Robert McLafferty, Springfield, United States |
16:25 - 16:30
Audience participation & discussion
16:30 - 16:35
Highlighting the easy victories when managing patients with swollen legs and lymphoedema
| Speaker: | Kristiana Gordon, London, United Kingdom |
16:35 - 16:40
Audience participation & discussion
16:40 - 16:45
Non-venous diagnoses that mimic C4-C6 venous skin changes
| Speaker: | Raghu Kolluri, Columbus, United States |
16:45 - 16:50
Audience participation & discussion
16:50 - 16:55
Edited Case: Technical considerations for optimal embolisation of low-flow vascular malformations
| Speaker: | Jocelyn Brookes, London, United Kingdom |
16:55 - 17:00
Audience participation & discussion
17:00 - 17:05
Lymphatic embolisation indications and techniques
| Speaker: | Tarun Sabharwal, London, United Kingdom |
17:05 - 17:10
Audience participation & discussion
Pelvic Venous Controversies
Time: 17:10 - 18:00
| Anchor: | Stephen Black, London, United Kingdom |
| Moderators: | Erin Murphy, Charlotte, United States |
| Alun Davies, London, United Kingdom |
17:10 - 17:15
Edited Case: Optimal technique for sclerotherapy of vulval varicosities
| Speaker: | Aleksandra Jaworucka-Kaczorowska, Gorzow Wielkopolski, Poland |
17:15 - 17:20
Audience participation & discussion
17:20 - 17:25
Treatment of pelvic venous disease to prevent leg varicosity recurrence
| Speaker: | Lindsay Machan, Vancouver, Canada |
17:25 - 17:30
Audience participation & discussion
17:30 - 17:35
Rationale for an RCT evaluating pelvic vein embolisation: Insights from the EMBOLIZE study
| Speaker: | Gloria Salazar, Chape Hill, United States |
17:35 - 17:40
Audience participation & discussion
17:40 - 17:45
Edited Case: Optimal technique for gonadal vein and pelvic venous reservoir embolisation
| Speaker: | Kathleen Gibson, Bellevue, United States |
17:45 - 17:50
Audience participation & discussion
17:50 - 17:55
The unbreakable rules of pelvic venous management
| Speaker: | Sriram Narayanan, Singapore, Singapore |
17:55 - 18:00
Audience participation & discussion